Home - Clinical Trials Arena
WEBModerna blamed after children offered £1,500 to take part in Covid-19 trial. Under the EU Clinical Trials Regulation, financial incentives are not allowed for participants under 16 to prevent undue influence. More themes. Artificial Intelligence. Cloud.
Gilead’s lenacapavir: HIV prospects strongest in long-acting …
WEBAug 25, 2021 · Gilead’s lenacapavir will find its strongest niche as a long-acting HIV combination treatment, experts said. Manasi Vaidya August 25, 2021. Gilead announced a collaboration with Merck in March to study lenacapavir with islatravir, a nucleoside reverse transcriptase translocation inhibitor (NRTTI), which is also a new drug class in HIV.
News - Clinical Trials Arena
WEBBiomea’s stock bounces back as FDA lifts clinical hold on diabetes trials. Biomea Fusion’s stock is on the up after the company plans to resume two clinical trials evaluating its type 1…. Phalguni Deswal. News.
Top Ongoing mRNA Herpes Vaccine Trials - Clinical Trials Arena
WEBFeb 2, 2023 · Pfizer and Moderna eye seasonal influenza. The two largest mRNA vaccine trials with readouts in 2023 are for seasonal influenza. First up, Moderna’s 6,102-patient, Phase III trial of mRNA-1010 (NCT05415462) has immunogenicity data expected in Q1 2023. The trial is testing mRNA-1010 against an …
All Newsletters - Clinical Trials Arena
WEBYour essential pharmaceutical and drug development news, covering new discoveries, research, big pharma trends & deals. Your essential read on industry innovations, from discoveries and R&D to clinical trials, manufacturing, and trends. Your medical device news digest covering respiratory, dental, neurology, cardiovascular, and orthopedic ...
Obesity: Six trials to watch over the next 12 months
WEBJun 30, 2023 · According to a report by GlobalData, the market for obesity drugs is predicted to be worth $37.1bn in 2031. GlobalData is a parent company of the Clinical Trials Arena. As more trials take place globally, not only will this help to provide a wider range of treatments for patients but will also assist the unmet need of lack of supply.
KERENDIA (finerenone) to Treat CKD Associated with Type 2 …
WEBSep 8, 2023 · KERENDIA (finerenone) is the first nonsteroidal mineralocorticoid receptor antagonist (MRA) indicated to reduce the risk of chronic kidney disease (CKD) associated with type 2 diabetes (T2D). Credit: Bayer. CKD associated with type 2 diabetes is the leading cause of renal failure worldwide. Credit: Kateryna Kon / Shutterstock.
pharmaceutical SMEs take the innovative edge - Clinical Trials Arena
WEBApr 18, 2012 · Small players, big drugs – pharmaceutical SMEs take the innovative edge. Medical advances are leading to more novel therapeutics but it's small biotech, not Big Pharma, which stands to gain the most. Elly Earls meets the brains behind some of the most innovative medicines currently breaking into the market to …
Bid Defenses – Considerations and Best Practices - Clinical Trials …
WEBJun 8, 2018 · Monitoring reports. Bid Defense – Final Considerations. Ultimately, the bid defense is a process that should be part presentation, but mostly a forum for discussion. The meeting should essentially serve as a microcosm of how a partnership between both parties could unfold. Both sides must be candid and …
BioNTech treats first subject in Phase II cancer vaccine trial
WEBOct 20, 2023 · BioNTech has treated the first subject in a Phase II clinical trial of cancer vaccine candidate, autogene cevumeran (BNT122, RO7198457) to treat resected pancreatic ductal adenocarcinoma (PDAC), a type of solid tumour. Autogene cevumeran is a messenger ribonucleic acid (mRNA)-based individualised neoantigen-specific immunotherapy (iNeST) candidate.